Literature DB >> 17483200

Differential aerobic exercise-induced changes in plasma aldosterone between African Americans and Caucasians.

Jennifer M Jones1, Thomas C Dowling, Jung-Jun Park, Dana A Phares, Joon-Young Park, Thomas O Obisesan, Michael D Brown.   

Abstract

Aldosterone influences the kidney's regulation of blood pressure (BP), but aldosterone can contribute to the pathogenesis of hypertension. Blood pressure is reduced with aerobic exercise training (AEX), but the extent to which plasma aldosterone (PA) levels change is unclear. The purpose of this study was to determine whether 6 months of AEX changed PA levels, 24 h sodium (Na(+)) excretion and BP in prehypertensive and hypertensive subjects and whether these changes differed according to ethnicity. The study was performed in the Kinesiology Department at the University of Maryland, College Park, and 35 (22 Caucasian; 13 African American) sedentary prehypertensive and hypertensive subjects completed 6 months of AEX. Blood samples were collected under fasting and supine conditions, and PA was measured by radioimmunoassay. In total population aerobic exercise training increased maximal oxygen consumption (24 +/- 0.8 versus 28 +/- 1 ml kg(-1) min(-1), P < 0.001) and decreased PA levels (97 +/- 11 versus 72 +/- 6 pg ml(-1), P = 0.01), body mass index (28 +/- 0.5 versus 28 +/- 0.5 kg m(-2), P = 0.004) and weight (85 +/- 2 versus 83 +/- 2 kg, P = 0.003). Aerobic exercise training decreased PA levels (from 119 +/- 16 to 81 +/- 7 pg ml(-1), P = 0.02) in the Caucasians but there was no change in BP or Na(+) excretion. African American participants had no significant changes in PA levels, BP and Na(+) excretion. Plasma aldosterone levels were 47% lower at baseline (P = 0.01) and 30% lower after AEX (P = 0.04) in African American participants compared with Caucasians. Baseline (P = 0.08) and final PA levels (P = 0.17) did not differ between the two groups after accounting for baseline and final intra-abdominal fat, respectively. The reduction in PA levels with AEX appeared to be driven by the change in PA levels in Caucasian participants. Fat distribution contributed to the ethnic differences in PA levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483200      PMCID: PMC2729146          DOI: 10.1113/expphysiol.2007.037408

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  44 in total

Review 1.  Neural control of renal function: cardiovascular implications.

Authors:  G F DiBona
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

2.  Endurance training and blood pressure in normotensive and hypertensive adults.

Authors:  R M Gilders; C Voner; G A Dudley
Journal:  Med Sci Sports Exerc       Date:  1989-12       Impact factor: 5.411

3.  Racial differences in aldosterone excretion and plasma aldosterone concentrations in children.

Authors:  J H Pratt; J J Jones; J Z Miller; M A Wagner; N S Fineberg
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

4.  Essential arterial hypertension: plasma and urinary aldosterone alterations.

Authors:  J L Garcia Zozaya; M Padilla Viloria; A Castro
Journal:  South Med J       Date:  1987-10       Impact factor: 0.954

5.  Physical training program in arterial hypertension. A long-term prospective follow-up.

Authors:  O Román; A L Camuzzi; E Villalón; C Klenner
Journal:  Cardiology       Date:  1981       Impact factor: 1.869

Review 6.  The renin-angiotensin system. Normal physiology and changes in older hypertensives.

Authors:  J E Hall; T G Coleman; A C Guyton
Journal:  J Am Geriatr Soc       Date:  1989-08       Impact factor: 5.562

7.  [Stability of steroids in plasma over a 10-year period].

Authors:  H K Kley; R Schlaghecke; H L Krüskemper
Journal:  J Clin Chem Clin Biochem       Date:  1985-12

8.  Serum aldosterone and the incidence of hypertension in nonhypertensive persons.

Authors:  Ramachandran S Vasan; Jane C Evans; Martin G Larson; Peter W F Wilson; James B Meigs; Nader Rifai; Emelia J Benjamin; Daniel Levy
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

9.  Effects of physical endurance training on the plasma renin-angiotensin-aldosterone system in normal man.

Authors:  P Hespel; P Lijnen; R Van Hoof; R Fagard; W Goossens; W Lissens; E Moerman; A Amery
Journal:  J Endocrinol       Date:  1988-03       Impact factor: 4.286

10.  Effect of exercise training in 60- to 69-year-old persons with essential hypertension.

Authors:  J M Hagberg; S J Montain; W H Martin; A A Ehsani
Journal:  Am J Cardiol       Date:  1989-08-01       Impact factor: 2.778

View more
  10 in total

1.  Effects of aerobic exercise on the blood pressure, oxidative stress and eNOS gene polymorphism in pre-hypertensive older people.

Authors:  Anderson Saranz Zago; Joon-Young Park; Nicola Fenty-Stewart; Leonardo Reis Silveira; Eduardo Kokubun; Michael D Brown
Journal:  Eur J Appl Physiol       Date:  2010-07-08       Impact factor: 3.078

2.  Reduction of plasma aldosterone and arterial stiffness in obese pre- and stage1 hypertensive subjects after aerobic exercise.

Authors:  S R Collier; K Sandberg; A M Moody; V Frechette; C D Curry; H Ji; R Gowdar; D Chaudhuri; M Meucci
Journal:  J Hum Hypertens       Date:  2014-05-01       Impact factor: 3.012

3.  The antihypertensive effects of aerobic versus isometric handgrip resistance exercise.

Authors:  Garrett I Ash; Beth A Taylor; Paul D Thompson; Hayley V MacDonald; Lauren Lamberti; Ming-Hui Chen; Paulo Farinatti; William J Kraemer; Gregory A Panza; Amanda L Zaleski; Ved Deshpande; Kevin D Ballard; Mohammadtokir Mujtaba; C Michael White; Linda S Pescatello
Journal:  J Hypertens       Date:  2017-02       Impact factor: 4.844

4.  Effects of continuous and interval training programs in the management of hypertension: a randomized controlled trial.

Authors:  Sikiru Lamina
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11       Impact factor: 3.738

5.  Improvements in insulin sensitivity and muscle blood flow in aerobic-trained overweight-obese hypertensive patients are not associated with ambulatory blood pressure.

Authors:  Paulo H Waib; Maria I Gonçalves; Silvia R Barrile
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-10       Impact factor: 3.738

6.  Effect of interval training program on white blood cell count in the management of hypertension: A randomized controlled study.

Authors:  S Lamina; C G Okoye
Journal:  Niger Med J       Date:  2011-10

7.  Deep-targeted sequencing of endothelial nitric oxide synthase gene exons uncovers exercise intensity and ethnicity-dependent associations with post-exercise hypotension.

Authors:  Linda S Pescatello; Elizabeth D Schifano; Garrett I Ash; Gregory A Panza; Lauren M L Corso; Ming-Hui Chen; Ved Deshpande; Amanda Zaleski; Burak Cilhoroz; Paulo Farinatti; Beth A Taylor; Rachel J O'Neill; Paul D Thompson
Journal:  Physiol Rep       Date:  2017-11

8.  The Association of Life's Simple 7 with Aldosterone among African Americans in the Jackson Heart Study.

Authors:  Veena Kesireddy; Yubo Tan; David Kline; Guy Brock; James B Odei; Bjorn Kluwe; Valery S Effoe; Justin B Echouffo Tcheugui; Rita R Kalyani; Mario Sims; Herman A Taylor; Morgana Mongraw-Chaffin; Ehimare Akhabue; Joshua J Joseph
Journal:  Nutrients       Date:  2019-04-26       Impact factor: 5.717

9.  Deep-targeted exon sequencing reveals renal polymorphisms associate with postexercise hypotension among African Americans.

Authors:  Linda S Pescatello; Elizabeth D Schifano; Garrett I Ash; Gregory A Panza; Lauren Lamberti; Ming-Hui Chen; Ved Deshpande; Amanda Zaleski; Paulo Farinatti; Beth A Taylor; Paul D Thompson
Journal:  Physiol Rep       Date:  2016-10-10

10.  FURIN variant associations with postexercise hypotension are intensity and race dependent.

Authors:  Burak T Cilhoroz; Elizabeth D Schifano; Gregory A Panza; Garrett I Ash; Lauren Corso; Ming-Hui Chen; Ved Deshpande; Amanda Zaleski; Paulo Farinatti; Lucas P Santos; Beth A Taylor; Rachel J O'Neill; Paul D Thompson; Linda S Pescatello
Journal:  Physiol Rep       Date:  2019-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.